Article citationsMore >>

López Méndez, P., Martín Santana, I., del Pino Reyes Yánez, M., Ruano Hernandez, A., Hernandez Beriain, J.A., Hervas Garcia, M. “Meningeal and Guillain–Barrè syndrome in a patient with rheumatoid arthritis receiving adalimumab therapy.” Reumatol Clín, 7: 401-3. 2011.

has been cited by the following article:

Article

Adalimumab Induced Aseptic Meningitis and Focal Partial Seizures in Patient with Crohn’s Disease

1Graduate Medical Education, UnityPoint Health-Des Moines, Des Moines, United States

2UnityPoint Clinic Multi-Specialty-Infectious Disease, UnityPoint Health, Des Moines, United States


American Journal of Medical Case Reports. 2019, Vol. 7 No. 11, 289-291
DOI: 10.12691/ajmcr-7-11-7
Copyright © 2019 Science and Education Publishing

Cite this paper:
Corey S. Ellis, Hayden L. Smith, Lisa A Veach. Adalimumab Induced Aseptic Meningitis and Focal Partial Seizures in Patient with Crohn’s Disease. American Journal of Medical Case Reports. 2019; 7(11):289-291. doi: 10.12691/ajmcr-7-11-7.

Correspondence to: Hayden  L. Smith, Graduate Medical Education, UnityPoint Health-Des Moines, Des Moines, United States. Email: hayden.smith@unitypoint.org

Abstract

Tumor necrosis factor α inhibitors (TNFα-i) are a commonly prescribed class of medications for the treatment of inflammatory bowel disease. With the increasing use of this medication class, some uncommon adverse effects have been reported. We present a case of a young male recently prescribed adalimumab for Crohn’s disease who developed aseptic meningitis with associated focal partial seizures.

Keywords